Program
2024
• Clinical and molecular pathology
• Digital pathology and artificial inteligence (AI)
• Interdisciplinary research in pathology
• Biomarkers in personalized medicine
• Molecular targets and novel cancer drugs
• Early cancer detection and prevention
• Multidisciplinary cancer research
• Translational research in oncology
• Data management and AI in cancer research
Keynote talks
Jonathan S. Duke-Cohan
T cell immunotherapies: Some molecular insights from the basic science perspective
Department of Medical Oncology, Dana
Farber Cancer Institute,Boston MA , USA
Viktor Umansky
Immunosuppression in tumor microenvironment mediated by myeloid-derived suppressor cells (MDSC)
German Cancer Research Center (DKFZ), Heidelberg, Germany
Ruprecht-Karl University of Heidelberg, Heidelberg, Germany
Jindřich Kopeček
Drug-Free Macromolecular Therapeutics
Center for Controlled Chemical Delivery, University of Utah, Salt Lake City, Utah, USA
Departments of Molecular Pharmaceutics and of Biomedical Engineering, Salt Lake City, Utah, USA
Richard Houlston
Opportunities to Deliver the Vision of Precision Oncology through Whole Genome Sequencing
Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom
David Khayat
Cancer Risk Factors: The Role of Tobacco Harm Reduction
Department of Medical Oncology at Pitié-Salpêtrière Hospital, in Paris, France
Oral presentation
Unless otherwise specified (e.g. for invited speakers) regular presentation is scheduled to 10-12 minutes of talk plus 3 minutes for discussion. Speakers are recommended to prepare slides in MS PowerPoint software.
Invited speaker presentation is scheduled to 30 minutes.
Poster presentation
Poster size: A0 841 mm (width) x 1189 (height)
Sponsors
Organizer
MedChemBio – cluster
Šlechtitelů 813/21
783 71 Olomouc-Holice
ID: 72023970
VAT: CZ72023970
Bank detail: 227436802/0300